tiprankstipranks
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Hong Kong Market
2126
JW (Cayman) Therapeutics Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:2126 full AI Analyst Report?

JW (Cayman) Therapeutics Co. Ltd. (2126) Income Statement

0 Followers

JW (Cayman) Therapeutics Co. Ltd. Income Statement

Last quarter (Q4 2025), JW (Cayman) Therapeutics Co. Ltd.'s total revenue was ¥174.35M, an increase of 102.46% from the same quarter last year. In Q4, JW (Cayman) Therapeutics Co. Ltd.'s net income was ¥-283.22M. See JW (Cayman) Therapeutics Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 276.31M¥ 158.22M¥ 173.86M¥ 145.70M¥ 30.80M
Gross Profit
¥ 118.91M¥ 77.32M¥ 88.22M¥ 58.76M¥ 9.04M
Operating Expenses
¥ 360.62M¥ 536.60M¥ 877.83M¥ 914.64M¥ 768.13M
Depreciation and Amortization
¥ 79.76M¥ 77.45M¥ 99.83M¥ 87.07M¥ 33.01M
EBITDA
¥ -161.95M¥ -381.58M¥ -655.75M¥ -752.27M¥ -738.70M
Operating Income
¥ -241.71M¥ -459.28M¥ -789.61M¥ -855.88M¥ -759.08M
Other Income/Expenses
¥ -296.22M¥ -131.34M¥ 21.61M¥ 9.75M¥ 56.76M
Pretax Income
¥ -537.93M¥ -590.62M¥ -768.00M¥ -846.13M¥ -702.33M
Net Income
¥ -540.92M¥ -590.62M¥ -768.00M¥ -846.13M¥ -702.33M
Per Share Metrics
Basic EPS
¥ -1.30¥ -1.43¥ -1.87¥ -2.06¥ -1.76
Diluted EPS
¥ -1.30¥ -1.43¥ -1.87¥ -2.06¥ -1.76
Weighted Average Shares Outstanding
 415.79M 413.63M 411.53M 410.09M 399.75M
Weighted Average Shares Outstanding (Diluted)
 415.79M 413.63M 411.53M 410.09M 399.75M
Currency in CNY

JW (Cayman) Therapeutics Co. Ltd. Earnings and Revenue History